As per our report, the global minimally invasive surgical instruments market size is expected to reach USD 47.90 billion by 2029 from USD 29.29 billion in 2024, growing at a CAGR of 10.19% during the forecast period.
Minimally invasive surgery reduces the number of incisions made during surgery, resulting in less stress on the body. As a result, this procedure is less painful, leaves fewer scars, and requires less time in the hospital. Constant technological advancements, a growth in chronic diseases, and increased medical tourism in poorer nations are all factors to consider. In contrast to traditional open surgery, surgeons in minimally invasive surgery employ various procedures to operate with the least amount of damage to the body. Minimally invasive techniques are beginning to replace traditional surgical care in different medical settings due to the development of real integrated solutions. The market's primary strategic initiatives include new product launches based on developing technologies, collaboration, mergers and acquisitions, and regional expansion. Conventional open operations are far more traumatic than minimally invasive surgeries. Surgical treatments using typical laparoscopic equipment can be painful and time-consuming. The operation is performed using minimally invasive laparoscopic cameras placed through smaller incisions and specialized smaller equipment. The market for minimally invasive surgical (MIS) devices is continually evolving due to technological advances, particularly in the sectors of cardiac, orthopedic, ophthalmology, neurological, and oral surgical procedures. To visualize tissue handling in inaccessible internal places, optical engineering and imaging technologies are applied. In the discipline of MIS, virtual reality (VR) is an important area of research in imaging technology. Before the real treatment approach is conducted in a care setting, VR can evaluate various problems and treatment options on virtual patients.
Compared to conventional open surgical, minimally invasive procedures are cost-effective, and expected to accelerate the market’s growth. In addition, minimally invasive surgery reduces the number of incisions performed in surgery to minimize trauma inflicted on the body. Furthermore, other factors such as medical tourism in emerging countries create awareness and offer multiple opportunities in the medical invasive instruments market. Moreover, the minimally invasive procedure requires less hospital stay and causes less pain and scarring.
On the other hand, growing government investments in the healthcare sector and improving healthcare infrastructure further boost the market. Furthermore, the benefits of traditional procedures over open surgeries and the proliferation of minimally invasive procedures worldwide ensure better market growth for the minimally invasive surgical instruments market. In addition, technological advancements in surgical procedures creating multiple market players opportunities to introduce innovative products will encourage market growth.
However, questions arise about the surgeries' quality; performing this method can reduce the minimally invasive surgical instruments market. Improper sterilization procedures and poor-quality assurance is the primary concern for the market growth. In addition, an uncertain framework in the medical device industry is another growth restraint factor to the minimally invasive surgical instruments market growth.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Product, Application, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Medtronic plc, Ethicon, Inc., Aesculap, Inc., Stryker Corporation, Smith & Nephew, ConMed Corporation, Abbott Laboratories, Applied Biomedical Resources Corporation, Microline Surgical, and Zimmer Biomet. |
Based on product type, the Minimally Invasive Surgical Instruments market is segmented into Handheld Instruments, Electro-Surgical Devices, Inflation Systems, Guiding Devices, Cutter Instruments, and Auxiliary Instruments. The handheld instrument segment reported the world market's highest share for minimally invasive surgical instruments by product last year among the mentioned segments. Furthermore, the segment of electrosurgical devices is projected to grow at the highest CAGR throughout the forecast period.
The orthopedic segment is estimated to show the global market's highest share for minimally invasive surgical instruments among the mentioned applications.
Based on the end-users, the segment of private hospitals & surgical clinics is projected to account for the global market's largest proportion for the end-users section.
Regionally, North America is projected to account for the most considerable portion of 34.2% of the global market for minimally invasive surgical devices in 2018. However, Asia-Pacific is estimated to rise at the most significant CAGR of 12.20% throughout the forecast period.
The rising geriatric population in Japan and China, road crashes, and emerging economies will foster the Asia Pacific Minimally Invasive Surgical Instruments market.
The most promising companies operating in the global minimally invasive surgical instruments market profiled in this report are Medtronic plc, Ethicon, Inc., Aesculap, Inc., Stryker Corporation, Smith & Nephew, ConMed Corporation, Abbott Laboratories, Applied Biomedical Resources Corporation, Microline Surgical, and Zimmer Biomet.
Last year, in terms of market presence, Medtronic was the global leader. Medtronic offers many coronary artery disease MIS technologies. The company has also established a spinal surgical method and a method of stabilization based on MIS procedures. In the last couple of years, the revenue growth rate of Medtronic was around 7 percent.
By Product
By Application
By End Users
By Region
Frequently Asked Questions
The global minimally invasive surgical instruments market was valued at USD 26.76 billion in 2023.
The growing prevalence of chronic diseases, the growing demand for minimally invasive procedures, the development of new surgical technologies, and the increasing adoption of robotic surgical systems are majorly propelling the growth of the minimally invasive surgical instruments market.
Medtronic, Johnson & Johnson, Olympus Corporation, Stryker Corporation, and Zimmer Biomet are some of the leading companies in the minimally invasive instruments market.
The high cost of these instruments, the need for specialized training and expertise to use them effectively, and the regulatory hurdles associated with bringing new surgical technologies to market are majorly challenging the growth of the minimally invasive surgical instruments market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region